A phase I trial of pegylated liposomal doxorubicin (PLD),...

Gynecologic Oncology 2015 / 04 Vol. 137

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: A Gynecologic Oncology Group study

Landrum, L.M., Brady, W.E., Armstrong, D.K., Moore, K.N., DiSilvestro, P.A., O'Malley, D.M., Tenney, M.E., Rose, P.G., Fracasso, P.M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.053
Date:
April, 2015
File:
PDF, 104 KB
english, 2015
Conversion to is in progress
Conversion to is failed